Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance (Usage Results Study) of Ixazomib Citrate in Patients With Multiple Myeloma in South Korea

NCT04840680 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04840680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04840680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance (Usage Results Study) of Ixazomib Citrate in Patients With Multiple Myeloma in South Korea
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
March 22, 2021
Completion date
August 28, 2023
Enrollment
191 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma